TY - JOUR
T1 - It's all about plant derived natural phytoconstituents and phytonanomedicine to control skin cancer
AU - Ashique, Sumel
AU - Afzal, Obaid
AU - Hussain, Afzal
AU - Zeyaullah, Md
AU - Altamimi, Mohammad A.
AU - Mishra, Neeraj
AU - Ahmad, Md Faruque
AU - Dua, Kamal
AU - Altamimi, Abdulmalik S.A.
AU - Anand, Krishnan
N1 - Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2023/6
Y1 - 2023/6
N2 - Nanotechnology is an emerging science for controlling cutaneous cancer and related consequences like skin melanoma. Phyto nanomedicine facilitated drug targeting, penetration, and retention with mitigated side effects as a result of topical application. Data and information were collected from various kinds of literature. Data were critically evaluated and analyzed. Due to the immense structural diversity found in them, natural resources continue to be a valuable source of new and innovative chemical entities with potential therapeutic value. Skin cancer (SC) is a deadly disease and a global challenge for healthcare professionals. Considering the frequent emergence of drug resistance, new drug discovery and clinical success are expensive and long-term processes. Therefore, phytochemicals emerged as a new window for therapeutic alternatives with convincing outcomes. These phytoconstituents and phytonanomedicines demonstrated to control SC through diverse mechanistic signaling pathways either by up-regulation or down-regulation. These have been explored in several in vitro and in vivo models. In this review, we addressed causes, pathology, and treatment options using phytonanomedicine or phytoconstituents to control SC followed by mechanistic perspectives. Perspectives on the most important phytochemicals and nanomedicines and their therapeutic potential are included in the current review.
AB - Nanotechnology is an emerging science for controlling cutaneous cancer and related consequences like skin melanoma. Phyto nanomedicine facilitated drug targeting, penetration, and retention with mitigated side effects as a result of topical application. Data and information were collected from various kinds of literature. Data were critically evaluated and analyzed. Due to the immense structural diversity found in them, natural resources continue to be a valuable source of new and innovative chemical entities with potential therapeutic value. Skin cancer (SC) is a deadly disease and a global challenge for healthcare professionals. Considering the frequent emergence of drug resistance, new drug discovery and clinical success are expensive and long-term processes. Therefore, phytochemicals emerged as a new window for therapeutic alternatives with convincing outcomes. These phytoconstituents and phytonanomedicines demonstrated to control SC through diverse mechanistic signaling pathways either by up-regulation or down-regulation. These have been explored in several in vitro and in vivo models. In this review, we addressed causes, pathology, and treatment options using phytonanomedicine or phytoconstituents to control SC followed by mechanistic perspectives. Perspectives on the most important phytochemicals and nanomedicines and their therapeutic potential are included in the current review.
KW - Future perspective
KW - Phytoconstituents
KW - Phytonanomedicines
KW - Recent advances to control skin cancer
KW - Skin cancer
UR - http://www.scopus.com/inward/record.url?scp=85156231845&partnerID=8YFLogxK
U2 - 10.1016/j.jddst.2023.104495
DO - 10.1016/j.jddst.2023.104495
M3 - Review article
AN - SCOPUS:85156231845
SN - 1773-2247
VL - 84
JO - Journal of Drug Delivery Science and Technology
JF - Journal of Drug Delivery Science and Technology
M1 - 104495
ER -